Literature DB >> 6191192

Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.

J Bouchard, R L Momparler.   

Abstract

In order to understand further the molecular mode of action of 5-Aza-2'-deoxycytidine (5-AZA-dCyd), a potent antileukemic agent, we prepared enzymatically 5-Aza-2'-deoxycytidine 5'-triphosphate (5-AZA-dCTP) and performed studies with purified DNA polymerase alpha and DNA methylase from mammalian cells. DNA polymerase alpha catalyzed the incorporation of 5-AZA-dCTP into DNA. The apparent Km value for 5-AZA-dCTP was estimated to be 3.0 microM; the Km of dCTP was 2.0 microM. The apparent Vmax of 5-AZA-dCTP was slightly lower than that for dCTP. 5-AZA-dCTP was a weak competitive inhibitor (Ki 4.3 microM) with respect to dCTP. Template studies with 5-AZA-dCTP showed that this nucleotide analogue was incorporated into poly(dIC), but not into poly(dAT), suggesting that the incorporation follows the rules of Watson-Crick base pairing. Incorporation of 5-AZA-dCTP into hemimethylated DNA produced a significant inhibition of DNA methylase. These results show that 5-AZA-dCTP is a very good substrate for DNA polymerase alpha and that its incorporation into DNA inhibits DNA methylation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191192

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  30 in total

1.  Binding of the EcoRII methyltransferase to 5-fluorocytosine-containing DNA. Isolation of a bound peptide.

Authors:  S Friedman; N Ansari
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

2.  Hordein promoter methylation and transcriptional activity in wild-type and mutant barley endosperm.

Authors:  M B Sørensen; M Müller; J Skerritt; D Simpson
Journal:  Mol Gen Genet       Date:  1996-04-10

3.  Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2'-deoxycytidine resistance.

Authors:  L A Michalowsky; P A Jones
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

4.  DNA Methylation Inhibitor Zebularine Confers Stroke Protection in Ischemic Rats.

Authors:  Hua Dock; Annette Theodorsson; Elvar Theodorsson
Journal:  Transl Stroke Res       Date:  2015-04-01       Impact factor: 6.829

5.  Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines.

Authors:  Aaron N Nguyen; Paul W Hollenbach; Normand Richard; Antonio Luna-Moran; Helen Brady; Carla Heise; Kyle J MacBeth
Journal:  Lung Cancer (Auckl)       Date:  2010-09-09

6.  Effects of 5'-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective.

Authors:  Amber Ilyas; Zehra Hashim; Shamshad Zarina
Journal:  Mol Cell Biochem       Date:  2015-04-09       Impact factor: 3.396

7.  Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation.

Authors:  P R Young; S M Tilghman
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

8.  DNA methylation, vernalization, and the initiation of flowering.

Authors:  J E Burn; D J Bagnall; J D Metzger; E S Dennis; W J Peacock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells.

Authors:  Pierre-Olivier Estève; Hang Gyeong Chin; Jack Benner; George R Feehery; Mala Samaranayake; Gregory A Horwitz; Steven E Jacobsen; Sriharsa Pradhan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

10.  Transbuccal delivery of 5-aza-2 -deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation.

Authors:  Ravichandran Mahalingam; Harish Ravivarapu; Sanjeev Redkar; Xiaoling Li; Bhaskara R Jasti
Journal:  AAPS PharmSciTech       Date:  2007-07-13       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.